foxo4-dri protocol | FOXO4/p53 Interaction Blocker FOXO4-DRI alleviates age-related testosterone secretion

In a further aspect of the invention, one or more chemical entities (e.g., nicotinamide riboside, nicotinamide mononucleotide) that increase intracellular NAD+ levels to provide muscular therapy is contacted with a cell expressing NNMT followed by contacting said cell expressing NNMT one or more NNMT inhibitors (such as a cation of Formula I or IA, or otherwise disclosed herein)

### Alternative: 2.5mg/mL (Better for Low Doses) | Vial Size | BAC Water to Add | Concentration | Volume per 0.5mg Dose | |-----------|-----------------|---------------|-----------------------| | 5mg | 2.0mL | 2.5mg/mL | 0.20mL | | 10mg | 4.0mL | 2.5mg/mL | 0.20mL | This lower concentration produces larger injection volumes easier to measure precisely, but more volume per shot

34 HUVECs plated on Matrigel in limiting medium with increasing concentrations of BPC-157 formed more extensive tubes in a dose-dependent manner (Figure 5EF)

Pregnant Women : The need for B12 increases during pregnancy, especially for those on plant-based diets